Antitumor Activities of Aqueous Cinnamon Extract on 5637 Cell Line of Bladder Cancer through Glycolytic Pathway
- PMID: 35990198
- PMCID: PMC9388315
- DOI: 10.1155/2022/3855368
Antitumor Activities of Aqueous Cinnamon Extract on 5637 Cell Line of Bladder Cancer through Glycolytic Pathway
Abstract
Background: Pharmacotherapy with medicinal plants is a promising approach to treat cancer. Cinnamon is a medicinal plant whose properties have been proven in various fields of medical sciences. Among its biological activities, its antioxidant and antiviral effects can be mentioned. In this study, the antitumor effects of Cinnamon with a focus on glucose metabolism in bladder cancer carcinoma cell-line 5637 were investigated.
Methods: Aqueous extract of Cinnamon was prepared from Cinnamon bark. Bladder cancer 5637cell line were treated with different concentrations of aqueous extract of Cinnamon. MTT was used to evaluate cell viability at 24, 48, and 72 h. The concentration of 1.25, 2.50, and 5 mg/ml was used. Apoptosis was assessed with Hochest33258 staining. For evaluating of aqueous extract of Cinnamon effect on glycolysis, the gene expression of epidermal growth factor receptor 2 (ErbB2), heat shock protein transcription factor1 (HSF1), and lactate dehydrogenase A (LDHA), as well as protein levels of HSF1 and LDHA, LDH activity, glucose consumption, and lactate production, were measured.
Results: Aqueous extract of Cinnamon significantly decreased ErbB2, HSF1, and LDHA gene expression and also decreased the protein level of HSF1 and LDHA, LDH activity, glucose consumption, and lactate production dose-dependently (p < 0.05).
Conclusion: Our finding showed that the aqueous extract of Cinnamon can inhibit proliferation in 5637 cells by inhibition of glycolysis and induction of apoptosis.
Copyright © 2022 Zeynab Aminzadeh et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures






Similar articles
-
Anticancer Effects of Cinnamaldehyde Through Inhibition of ErbB2/HSF1/LDHA Pathway in 5637 Cell Line of Bladder Cancer.Anticancer Agents Med Chem. 2022;22(6):1139-1148. doi: 10.2174/1871520621666210726142814. Anticancer Agents Med Chem. 2022. PMID: 34315398
-
ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis.Med Oncol. 2022 Jan 29;39(4):45. doi: 10.1007/s12032-021-01641-4. Med Oncol. 2022. PMID: 35092510
-
Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.Oncogene. 2009 Oct 22;28(42):3689-701. doi: 10.1038/onc.2009.229. Epub 2009 Aug 10. Oncogene. 2009. PMID: 19668225
-
The Anti-Cancer Effect of Cinnamon Aqueous Extract: A Focus on Hematological Malignancies.Life (Basel). 2023 May 12;13(5):1176. doi: 10.3390/life13051176. Life (Basel). 2023. PMID: 37240821 Free PMC article. Review.
-
Aqueous Extract of Cinnamon (Cinnamomum spp.): Role in Cancer and Inflammation.Evid Based Complement Alternat Med. 2023 May 11;2023:5467342. doi: 10.1155/2023/5467342. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 37215636 Free PMC article. Review.
Cited by
-
An Analysis of the Toxicity, Antioxidant, and Anti-Cancer Activity of Cinnamon Silver Nanoparticles in Comparison with Extracts and Fractions of Cinnamomum Cassia at Normal and Cancer Cell Levels.Nanomaterials (Basel). 2023 Mar 5;13(5):945. doi: 10.3390/nano13050945. Nanomaterials (Basel). 2023. PMID: 36903823 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous